AI-Powered Public Health Technology
Our platform combines advanced machine learning, epidemiological modeling, and ethical AI principles to deliver actionable public health intelligence at scale.
Our platform combines advanced machine learning, epidemiological modeling, and ethical AI principles to deliver actionable public health intelligence at scale.
APHI uses established AI and data science methods only where they can be tied to a public health workflow, data governance plan, and evaluation standard.
Deep learning models for pattern recognition in health data, including convolutional neural networks for medical imaging, recurrent networks for time-series forecasting, and transformer architectures for clinical text analysis.
NLP can extract structured signals from unstructured sources such as clinical notes, death certificates, news reports, and public communications. Operational use requires source review and human oversight.
Automated analysis of medical images, satellite imagery for environmental health monitoring, and visual detection of disease vectors through drone and sensor networks.
Predictive models for disease incidence, hospital capacity, and resource needs. We use ARIMA, Prophet, LSTM networks, and ensemble methods to forecast public health trends with quantified uncertainty.
Spatial statistics and GIS integration identify disease clusters, track transmission pathways, and optimize intervention geography. Our models account for spatial autocorrelation and environmental factors.
Causal methods can help estimate intervention effects, but policy use requires careful assumptions, transparent uncertainty, and external review.
Multi-Source Ingestion: Our platform ingests data from electronic health records (HL7 FHIR), syndromic surveillance systems, laboratory networks, vital statistics, environmental sensors, social determinants databases, and open data sources.
Interoperability Standards: We adhere to public health data standards including FHIR, SNOMED CT, ICD-10, and LOINC, supporting integration with existing health IT infrastructure.
Real-Time Pipelines: Stream processing enables sub-minute latency for critical signals, while batch processing handles large-scale retrospective analyses.
Model Library: Pre-trained models for common public health tasks (influenza forecasting, outbreak detection, vaccine hesitancy prediction) can be fine-tuned to local contexts.
AutoML Capabilities: Automated hyperparameter tuning and model selection reduce the need for specialized ML expertise, democratizing access to sophisticated analytics.
Ensemble Methods: We combine multiple algorithms to improve accuracy and robustness. No single model is perfect; ensemble approaches hedge against individual model failures.
Differential Privacy: Mathematical guarantees that individual-level data cannot be reverse-engineered from aggregate statistics, enabling safe data sharing.
Federated Learning: Models train across distributed datasets without centralizing sensitive information. Institutions maintain data sovereignty while contributing to collective intelligence.
Encryption & Access Control: End-to-end encryption, role-based access control, audit logging, and HIPAA/GDPR compliance are built into every layer of our infrastructure.
AI for public health must be developed and deployed responsibly. We follow rigorous ethical principles aligned with WHO guidance and CDC best practices, ensuring safe and secure AI implementation with human oversight and research excellence at every stage.
Bias Auditing: Prototypes must be tested for data gaps and differential performance across relevant demographic and geographic groups.
Representative Data: Training datasets must be reviewed for missingness, underrepresentation, and collection bias before deployment.
Equity Metrics: Model performance is evaluated not just on average accuracy, but on equity metrics ensuring benefits are distributed fairly.
Interpretable Models: When possible, we use inherently interpretable algorithms (decision trees, linear models, GAMs). For complex deep learning, we apply SHAP values, LIME, and attention visualization.
Model Cards: Every prototype should have a model card detailing intended use, excluded use, data requirements, limitations, validation needs, and governance.
Stakeholder Communication: Technical outputs are translated into plain language for policymakers and communities, with clear uncertainty quantification.
Human Oversight: Following CDC guidance, AI systems augment, not replace, human judgment. Every AI solution is developed with human oversight to ensure responsible deployment and trustworthy outcomes.[5]
Continuous Monitoring: Drift detection, reviewer feedback, and incident review are required before any operational claim.
Ethics Review: High-impact deployments should include external public health, ethics, and community review before scale.
Purpose Limitation: Data is used only for specified public health purposes. No commercial use, no re-identification attempts, no mission creep.
Minimal Data Collection: We collect only what is necessary. Privacy-preserving techniques reduce raw data requirements.
Data Retention Policies: Clear schedules for data retention and secure deletion, compliant with legal requirements and ethical best practices.
Anomaly detection algorithms identify unusual patterns in syndromic surveillance data, lab results, and social signals. Bayesian methods quantify evidence strength, reducing false alarms.
Multi-week ahead forecasts for influenza, COVID-19, and other infectious diseases. Ensemble models combine mechanistic epidemiological models with data-driven ML approaches.
Identify communities, programs, or geographies that may need additional review. Individual-level use requires separate clinical and ethical governance.
Operations research and reinforcement learning optimize vaccine distribution, testing site placement, and healthcare workforce allocation under resource constraints.
NLP analyzes social media, search trends, and surveys to understand health behaviors, vaccine hesitancy, and misinformation spread, informing communication strategies.
Agent-based models and system dynamics simulations can compare intervention scenarios before implementation, but outputs should be treated as planning inputs, not predictions of certainty.
Models should be evaluated using temporal cross-validation, spatial cross-validation, and prospective shadow review before operational use.
APHI will publish performance metrics only when supported by public sources or partner-approved evaluations, with scope and limitations attached.
Our development processes align with FDA guidance on software as a medical device, ONC interoperability standards, and CDC data quality frameworks.
For clinical decision support tools, we follow evidence-based medicine principles and pursue appropriate regulatory clearances where required.
All predictions include confidence intervals and uncertainty estimates. We use Bayesian methods, bootstrapping, and ensemble approaches to characterize uncertainty.
Communicating what we don't know is as important as communicating what we do know. Overconfident predictions erode trust and lead to poor decisions.
Significant methodological claims should be submitted for peer review or released with enough documentation for independent scrutiny.
Open science practices such as preregistration, code sharing, and open data should be used where privacy and partner agreements allow.
Learn more about how our AI platform can support your public health initiatives, or explore our research publications and technical documentation.